Corpus ID: 16797292

The Effect of Optaflexx ® on Growth Performance and Carcass Traits of Calf-fed Holstein Steers Fed to Harvest A Summary of Four Post-approval Studies

@inproceedings{Vogel2005TheEO,
  title={The Effect of Optaflexx ® on Growth Performance and Carcass Traits of Calf-fed Holstein Steers Fed to Harvest A Summary of Four Post-approval Studies},
  author={G. J. Vogel and Angel Xavier Astudillo Aguilar and Aubrey L. Schroeder and William J. Platter and Brian Scott and Laudert and Michael T. Van Koevering},
  year={2005}
}
Optaflexx is Elanco’s trademark name for ractopamine hydrochloride, the first beta-agonist to be approved by the United States Food and Drug Administration (FDA) for increased rate of weight gain, improved feed efficiency and increased carcass leanness* when fed to steers and heifers during the final 28 to 42 days of the finishing period. The effects of Optaflexx fed to beef steers during the FDA registration studies are presented in Optaflexx Exchange No. 1, while the effects of Optaflexx fed… CONTINUE READING

Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

References

Publications referenced by this paper.
SHOWING 1-2 OF 2 REFERENCES

The Effect of Optaflexx on Growth Performance and Carcass Traits of Steers, Summary of Six Post-registration Studies

  • S. B. Laudert, G. J. Vogel, A. L. Schroeder, W. J. Platter, M. T. Van Koevering.
  • Optaflexx Exchange #4, Elanco Animal Health. AI9725
  • 2004
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

The Effect of Optaflexx on Growth Performance and Carcass Traits of Steers, Five-Trial Registration Summary, Optaflexx Exchange #1

  • A. L. Schroeder, D. M. Polser, S. B. Laudert, G. J. Vogel.
  • Elanco Animal Health. AI9251
  • 2003
VIEW 1 EXCERPT